Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) EBIT Margin (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of EBIT Margin data on record, last reported at 13.46% in Q4 2025.

  • For Q4 2025, EBIT Margin rose 520.0% year-over-year to 13.46%; the TTM value through Dec 2025 reached 11.53%, up 415.0%, while the annual FY2025 figure was 8.52%, 328.0% up from the prior year.
  • EBIT Margin reached 13.46% in Q4 2025 per PAHC's latest filing, down from 14.09% in the prior quarter.
  • Across five years, EBIT Margin topped out at 14.09% in Q3 2025 and bottomed at 0.31% in Q3 2023.
  • Average EBIT Margin over 5 years is 8.11%, with a median of 8.13% recorded in 2022.
  • Peak YoY movement for EBIT Margin: plummeted -620bps in 2023, then surged 729bps in 2025.
  • A 5-year view of EBIT Margin shows it stood at 9.58% in 2021, then tumbled by -32bps to 6.48% in 2022, then decreased by -3bps to 6.28% in 2023, then soared by 31bps to 8.26% in 2024, then soared by 63bps to 13.46% in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT Margin were 13.46% in Q4 2025, 14.09% in Q3 2025, and 8.9% in Q2 2025.